Jane Street Group, LLC G1 Therapeutics, Inc. Call Options Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	BUY	$7.6 - $11.02 $178,600 - $258,970	23,500 Added 133.52%	41,100 $312,000
Q4 2021 Feb 15, 2022	SELL	$10.16 - $16.17 $273,304 - $434,973	-26,900 Reduced 60.45%	17,600 $180,000
Q3 2021 Nov 16, 2021	SELL	$13.16 - $22.47 $114,492 - $195,489	-8,700 Reduced 16.35%	44,500 $597,000
Q2 2021 Aug 16, 2021	BUY	$19.57 - $26.32 $105,678 - $142,128	5,400 Added 11.3%	53,200 $1.17 Million
Q1 2021 May 18, 2021	BUY	$17.58 - $32.59 $17,580 - $32,590	1,000 Added 2.14%	47,800 $1.15 Million
Q4 2020 Feb 17, 2021	BUY	$10.99 - $20.4 $514,332 - $954,719	46,800 New	46,800 $842,000

3.71M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.